By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sanofi Pasteur 

174, av. de France

Paris    75013  France
Phone: 33-1-53-77-4076 Fax: 33-1-53-77-4174


SEARCH JOBS


Industry
Biotechnology






Company News
Sanofi Pasteur (SASY.PA)'s Investigational Dengue Vaccine Hits Main Goal Showing Efficacy In Phase 3 Trial 11/4/2014 6:15:14 AM
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Updated Prescribing Information For Fluzone® High-Dose Vaccine For Adults 65 And Older 11/3/2014 8:29:47 AM
FDA Accepts For Review A Biologics License Application For Merck & Co. (MRK) And Sanofi Pasteur (SASY.PA)’s Investigational Pediatric Hexavalent Vaccine 10/20/2014 7:51:47 AM
Sanofi Pasteur (SASY.PA) And Immune Design Corporation (IMDZ) Enter Broad Collaboration For The Development Of A Herpes Simplex Virus Therapy 10/16/2014 7:28:50 AM
Sanofi Pasteur (SASY.PA) Release: FDA Approves Use Of Menactra® Vaccine For Booster Immunization Against Potentially Deadly Disease 9/9/2014 7:25:31 AM
Sanofi Pasteur (SASY.PA) Touts Positive Trial Data For Fluzone High-Dose Vaccine 8/14/2014 6:26:10 AM
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014 1:44:14 PM
Sanofi Pasteur (SASY.PA) Dengue Vaccine Promising But Questions Remain 7/11/2014 6:36:50 AM
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In Europe For The Prevention Of Anal Cancer 6/18/2014 9:17:27 AM
Sanofi Pasteur (SASY.PA) Announces Favorable Phase 2 Study Results For Investigational Clostridium difficile Vaccine At The American Society for Microbiology Meeting 5/19/2014 7:43:22 AM
12345678910...
//-->